<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Динамика биомаркеров некроза миокарда и параметров кислотно-щелочного состояния при коронарном шунтировании на «работающем сердце» у больных сахарным диабетом 2 типа в зависимости от режима периоперационной гипогликемической терапии</article-title><trans-title-group xml:lang="en"><trans-title>Dynamics of myocardial necrosis biomarkers and acid-base balance parameters after coronary artery bypass grafting on beating-heart depending on the perioperative glucose-lowering treatment regimen in patients with type II diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бородашкина</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Borodashkina</surname><given-names>S. Y.</given-names></name></name-alternatives><email xlink:type="simple">chernigas@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Протасов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Protasov</surname><given-names>K. V.</given-names></name></name-alternatives><email xlink:type="simple">k.v.protasov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Подкаменный</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Podkamennyi</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">pvdm@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Иркутская ордена «Знак почета» областная клиническая больница»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБОУ ДПО «Иркутская государственная медицинская академия последипломного образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Continuing Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>28</day><month>11</month><year>2015</year></pub-date><volume>0</volume><issue>6</issue><fpage>11</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бородашкина С.Ю., Протасов К.В., Подкаменный В.А., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Бородашкина С.Ю., Протасов К.В., Подкаменный В.А.</copyright-holder><copyright-holder xml:lang="en">Borodashkina S.Y., Protasov K.V., Podkamennyi V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/131">https://www.actabiomedica.ru/jour/article/view/131</self-uri><abstract><p>Изучена взаимосвязь динамики маркеров некроза миокарда с режимом периоперационной сахароснижающей терапии, параметрамиуглеводного обмена и кислотно-щелочного состояния при коронарном шунтировании у больных сахарным диабетом 2-го типа. Больший прирост маркеров некроза миокарда отмечен у пациентов, находящихся на лечении инсулином. Динамика тропонина Т и МВ-фракции креатинфосфокиназы коррелировала с уровнем глюкозы во время операции, вариабельностью гликемии накануне операции и при поступлении.</p></abstract><trans-abstract xml:lang="en"><p>The study included 71 patient with ischemic coronary disease (ICD) with type II diabetes mellitus (DM) treated by oral hypoglycemic agents undergoing off-pump coronary artery bypass grafting (CABG). The mean age was 59 (56-64) years. Before the surgery the patients were randomized to continuing of oral hypoglycemic agents (n = 34) or to switching to rapid-acting insulin (n = 37). In the studied groups we compared glycemic parameters, markers of myocardial necrosis (troponin T and creatinine phosphokinase-MB (CPK-MB)) and acid-base balance, as well as their dynamics during the perioperative period. The relationships of myocardial necrosis markers dynamics with glucose metabolism and acid-base balance parameters were investigated. Before the surgery in switched to rapid-acting insulin patients serum glucose, its daily variability and the proportion of blood glucose values less than recommended perioperative range (6,1-10,0 mmol/l) were higher than in those at oral hypoglycemic agents. The myocardial necrosis markers at the day before and 24 h after surgery as well as lactate level and blood acidity during and at 24 hours after surgery were higher in the insulin-group. The insulin-group was characterized by greater increase of troponin T during 24 h after surgery (0,36 [0,25-0,40] vs 0,2 [0,1-0,25] ng/ml; p &lt; 0,001) and CPK-MB (14 [8,0-17,0] vs 7,3 [1,5-8,7] U/L; p &lt; 0,001). Troponin T and CPK-MB dynamics correlated with serum glucose during surgery (r = +0,81 and r = +0,66 respectively), daily serum glucose variability at the day before surgery (r = +0,71 and r = +0,63) and the first day of admission to hospital (r = +0,37 and r = +0,31).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коронарное шунтирование</kwd><kwd>сахарный диабет</kwd><kwd>пероральные сахароснижающие препараты</kwd><kwd>инсулин</kwd><kwd>тропонин Т</kwd><kwd>МВ-креатинфосфокиназа</kwd><kwd>кислотно-щелочное состояние</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary artery bypass surgery</kwd><kwd>diabetes mellitus</kwd><kwd>oral hypoglycemic agents</kwd><kwd>insulin</kwd><kwd>troponin T</kwd><kwd>creatinine phosphokinase-MB</kwd><kwd>acid-base status</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гибельгаус М.А., Кремнева Л.В., Нелаев B.C., Крючев Н.В., Абатурова О.В. Оценка взаимосвязи уровня тропонина Т после коронарного шунтирования с клинико-ангиографическими характеристиками и показателями оперативного вмешательства у больных ИБС // Матер. V съезда кардиологов Уральского федерального округа. - Екатеринбург, 2011. - С. 94</mixed-citation><mixed-citation xml:lang="en">Гибельгаус М.А., Кремнева Л.В., Нелаев B.C., Крючев Н.В., Абатурова О.В. Оценка взаимосвязи уровня тропонина Т после коронарного шунтирования с клинико-ангиографическими характеристиками и показателями оперативного вмешательства у больных ИБС // Матер. V съезда кардиологов Уральского федерального округа. - Екатеринбург, 2011. - С. 94</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом», 7 выпуск // Сахарный диабет. -2015. - № 18 (1S). - С. 1-112</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом», 7 выпуск // Сахарный диабет. -2015. - № 18 (1S). - С. 1-112</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Максимова М.А. Федеральная целевая программа «Сахарный диабет»: Метод. рекомендации. - М., 2002</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Шестакова М.В., Максимова М.А. Федеральная целевая программа «Сахарный диабет»: Метод. рекомендации. - М., 2002</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Комиссарова Е.С., Беляева Н.Г., Тезяева С.А., Стронгин Л.Г. Интенсивная инсулинотерапия у больных хирургического профиля с сахарным диабетом 2-го типа // Современные технологии в медицине. - 2013. - T. 5, № 1. - С. 64-69</mixed-citation><mixed-citation xml:lang="en">Комиссарова Е.С., Беляева Н.Г., Тезяева С.А., Стронгин Л.Г. Интенсивная инсулинотерапия у больных хирургического профиля с сахарным диабетом 2-го типа // Современные технологии в медицине. - 2013. - T. 5, № 1. - С. 64-69</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации по лечению стабильной ишемической болезни сердца. ESC 2013 // Российский кардиологический журнал. - 2014. - № 7 (111). - С. 7-79</mixed-citation><mixed-citation xml:lang="en">Рекомендации по лечению стабильной ишемической болезни сердца. ESC 2013 // Российский кардиологический журнал. - 2014. - № 7 (111). - С. 7-79</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart]., 34, 3035-3087.</mixed-citation><mixed-citation xml:lang="en">ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart]., 34, 3035-3087.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart]., 35 (37), 2541-2619.</mixed-citation><mixed-citation xml:lang="en">ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart]., 35 (37), 2541-2619.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bansilal S., Farkouh M.E., Hueb W. (2012). The future revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am. Heart]., 164 (4), 591-599.</mixed-citation><mixed-citation xml:lang="en">Bansilal S., Farkouh M.E., Hueb W. (2012). The future revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am. Heart]., 164 (4), 591-599.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Deedwania P., Kosiborod M., Barrett E. et al. (2008) Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation, 117, 1610-1619.</mixed-citation><mixed-citation xml:lang="en">Deedwania P., Kosiborod M., Barrett E. et al. (2008) Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation, 117, 1610-1619.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Duckworth W., Abraira C., Moritz T. et al. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl.]. Med., 360 (2), 129-139.</mixed-citation><mixed-citation xml:lang="en">Duckworth W., Abraira C., Moritz T. et al. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl.]. Med., 360 (2), 129-139.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobi J., Bircher N., Krinsley J. et al. (2012). Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit. Care Med., 40, 3251-3276.</mixed-citation><mixed-citation xml:lang="en">Jacobi J., Bircher N., Krinsley J. et al. (2012). Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit. Care Med., 40, 3251-3276.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Marik P.E., Preiser J.C. (2010). Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest, 137, 544-551.</mixed-citation><mixed-citation xml:lang="en">Marik P.E., Preiser J.C. (2010). Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest, 137, 544-551.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nashef S.A., Roques F., Sharples L.D. et al. (2012.) EuroSCORE II. Eur.]. Cardiothorac. Surg., 41 (4), 734-744.</mixed-citation><mixed-citation xml:lang="en">Nashef S.A., Roques F., Sharples L.D. et al. (2012.) EuroSCORE II. Eur.]. Cardiothorac. Surg., 41 (4), 734-744.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Saisho Y. (2014). Glycemic variability and oxidative stress: A link between diabetes and cardiovascular disease? Int.]. Mol. Sci., 15, 18381-18406.</mixed-citation><mixed-citation xml:lang="en">Saisho Y. (2014). Glycemic variability and oxidative stress: A link between diabetes and cardiovascular disease? Int.]. Mol. Sci., 15, 18381-18406.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Skyler J.S., Bergenstal R., Bonow B.O. et al. (2009). Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care, 32, 187-192.</mixed-citation><mixed-citation xml:lang="en">Skyler J.S., Bergenstal R., Bonow B.O. et al. (2009). Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care, 32, 187-192.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Subramaniam B., Lerner A., Novack V. et al. (2014). Increased glycemic variability in patients with elevated preoperative HbA1c predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth. Analg, 118 (2), 277-287.</mixed-citation><mixed-citation xml:lang="en">Subramaniam B., Lerner A., Novack V. et al. (2014). Increased glycemic variability in patients with elevated preoperative HbA1c predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth. Analg, 118 (2), 277-287.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">The BARI 2D Study Group: A randomized trial of therapies for type 2 diabetes and coronary artery disease (2009) N. Engl.]. Med., 360, 2503-2515.</mixed-citation><mixed-citation xml:lang="en">The BARI 2D Study Group: A randomized trial of therapies for type 2 diabetes and coronary artery disease (2009) N. Engl.]. Med., 360, 2503-2515.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Thygesen K., Alpert J.S., Jaffe A.S. et al. (2012). Third universal definition of myocardial infarction. Eur. Heart]., 33 (20), 2551-2567.</mixed-citation><mixed-citation xml:lang="en">Thygesen K., Alpert J.S., Jaffe A.S. et al. (2012). Third universal definition of myocardial infarction. Eur. Heart]., 33 (20), 2551-2567.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">U.K. Hypoglycaemia Study Group (2007). Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia, 50, 1140-1147.</mixed-citation><mixed-citation xml:lang="en">U.K. Hypoglycaemia Study Group (2007). Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia, 50, 1140-1147.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
